Skip to content
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$34.17M-4.2%-$32.79M-26.9%-$25.83M+49.5%-$51.11M-135%-$21.76M-5.5%
$1.98M-16.4%$2.37M+17.0%$2.03M+10.5%$1.84M-2.8%$1.89M+1.0%
$10.11M+16.8%$8.65M+89.0%$4.58M-79.5%$22.31M+4,761%$459K-59.1%
$16K0.0%$16K0.0%
$469K+0.2%$468K-0.2%$469K+27.1%$369K+117%$170K-74.3%
-$167K+40.4%-$280K0.0%-$280K+76.9%-$1.21M-301%-$302K+7.1%
$2.66M+56.1%$1.71M-4.1%$1.78M+84.5%$963K-71.2%$3.34M+112%
-$2.9M$4.01M+254%
$3.67M+166%$1.38M+260%-$860K-146%$1.89M+99.9%$944K-42.6%
-$10K0.0%-$10K0.0%-$10K0.0%-$10K0.0%-$10K0.0%
-$228K-30.3%-$175K-26.8%-$138K-197%$142K+36.5%$104K+2.0%
-$18.37M-0.1%-$18.34M+30.2%-$26.27M-9.2%-$24.06M-33.7%-$18M+0.3%
$9.8M+34.9%$7.27M-11.0%$8.17M+10.5%$7.39M+81.9%$4.06M-8.6%
-$14.92M-101%-$7.42M+9.9%-$8.23M-11.2%-$7.4M-66.4%-$4.45M-0.7%
$53.95M0.0%$53.95M0.0%
$149.18M+552,626%-$27K+98.6%-$1.88M-101%$214.7M
$115.9M+549%-$25.79M+29.1%-$36.38M-120%$183.24M
$1.42M0.0%$1.42M+16.4%$1.22M+3.7%$1.18M-4.3%
$25K-$39K-2,050%$2K-94.7%$38K
$469K+0.2%$468K-0.2%$469K+27.1%$369K+117%$170K-74.3%
$3.67M+166%$1.38M+260%-$860K-146%$1.89M+99.9%$944K-42.6%
-$136K+70.4%-$460K+25.8%-$620K+63.7%-$1.71M-229%
-$228K-30.3%-$175K-26.8%-$138K-197%$142K+36.5%$104K+2.0%
-$813K-481%-$140K-110%$1.42M+276%$378K
$125K+43.7%$87K+42.6%$61K-29.1%$86K-2.3%$88K-2.2%
$152K-35.6%$236K+0.9%
$365K-32.0%$537K-12.4%$613K-24.4%$811K+0.2%$809K+120%
$699K$170K
$189K-19.6%$235K+128%$103K+268%$28K-93.5%$430K+143%
$67K-16.3%$80K+116%$37K+185%$13K-69.8%$43K-78.9%
$6K-88.0%$50K-91.3%
$880.75K0.0%$880.75K0.0%
$84K$69K
$593.5K0.0%$593.5K0.0%
$468.75K0.0%$468.75K0.0%
$70.13M0.0%$70.13M0.0%
-$232K-$2.91M-539%$662K0.0%$662K0.0%
-$228K-30.3%-$175K-26.8%-$138K-197%$142K+36.5%$104K+2.0%
$1.36M0.0%$1.36M0.0%
$959K-32.1%$1.41M-79.5%$6.9M$707K
$25K-$39K-2,050%$2K-94.7%$38K
-$28.16M-10.0%-$25.61M+25.6%-$34.44M-9.5%-$31.45M-42.5%-$22.06M+2.0%
-$28.16M-10.0%-$25.61M+25.6%-$34.44M-9.5%-$31.45M-42.5%-$22.06M+2.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.